Stock Events

Stock Events

ARS Pharmaceuticals (SPRY) Q4 2024 Earnings

13NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.2

-0.16

-0.11

-0.07

Details

Expected EPS

-0.1425

Actual EPS

-0.2

Surprise EPS

-0.06

Surprise Percent

+40.35%

Description

ARS Pharmaceuticals (SPRY) has reported earnings of -0.2 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.